Allergy Therapeutics annual operating margin
2022
2023
2024
2025
Allergy Therapeutics's operating margin was −51.16% for fiscal 2025.
View full Allergy Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-06-30 | −51.16% | +10.47 pp |
| 2024 | 2024-06-30 | −61.63% | −3.05 pp |
| 2023 | 2023-06-30 | −58.58% | −41.75 pp |
| 2022 | 2022-06-30 | −16.83% | — |
Between the periods ended 2022-06-30 and 2025-06-30, Allergy Therapeutics's operating margin decreased from −16.83% to −51.16%, a change of −34.34 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Allergy Therapeutics source filings ↗